• ddATP Workflows for DNA Synthesis Control

  2026-10-01

  Use ddATP to terminate DNA synthesis selectively, tune A-dependent extension, and test replication-linked damage in biochemical and cell-based assays. This guide connects the molecule’s chain-termination chemistry with oocyte DNA-repair findings, practical assay design, and troubleshooting decisions.

• Bafilomycin C1 in High-Content Phenotypic Screens

  2026-10-01

  Bafilomycin C1 gives researchers a controlled way to perturb lysosomal acidification while separating autophagy flux, cellular stress, and imaging phenotypes. This guide connects V-ATPase inhibition with iPSC-cardiomyocyte screening, deep-learning analysis, and practical troubleshooting.

• GI 254023X: ADAM10 Inhibitor Workflow Guide

  2026-09-30

  GI 254023X enables selective ADAM10 inhibition for dissecting Notch1 signaling, Jurkat-cell phenotypes, and endothelial barrier protection. This guide translates product specifications and a quantitative assay-design lesson from neuronal research into practical workflows with controls, optimization steps, and troubleshooting.

• Vancomycin Hydrochloride: From Target to Assay

  2026-09-30

  Explore how Vancomycin hydrochloride connects molecular target engagement with bacterial susceptibility testing, resistance interpretation, and translational infection models. This guide adds an evidence-based assay framework beyond routine workflow protocols.

• N-octanoyl-L-Homoserine lactone Workflows

  2026-09-29

  Use N-octanoyl-L-Homoserine lactone as a defined C8-HSL stimulus to connect quorum sensing with biofilm phenotypes, virulence signaling, and host-cell responses. This guide combines concentration-controlled assays, pathway-resolved cancer models, and practical troubleshooting for infection biology research.

• Farnesyl Alcohol Azide: KRAS Biology Guide

  2026-09-29

  Farnesyl Alcohol Azide is a C4380 product whose supplied dossier does not include a structure, purity, or validated assay protocol. A 2026 Cell study links KRAS farnesylation at C185 to liquid-liquid phase separation, RCE1 clustering, colon tumor growth, and altered response to KRAS G12C inhibition, but it does not establish that C4380 produces these effects.

• WM-8014: Time-Gated Epigenetic Assay Design

  2026-09-28

  WM-8014 is a reversible KAT6A inhibitor for separating target engagement, cell-cycle arrest, and senescence in complex cancer models. This guide connects its mechanism to time-gated CRISPR logic and practical assay design for cancer biology research.

• Octanoic Acid-Rich Enteral Nutrition in IBD

  2026-09-28

  A 2025 study reports that octanoic acid-rich enteral nutrition alleviated experimental inflammatory bowel disease while shifting intestinal macrophage polarization through a PPARγ/STAT-1/STAT-6 signaling axis. Intervention experiments and macrophage cell studies support a functional role for this pathway, although the findings remain preclinical and do not establish clinical efficacy.

• Direct Mouse Genotyping Kit Plus for EP4 Studies

  2026-09-27

  A purification-free lysate workflow can simplify routine mouse genotyping for macrophage and atherosclerosis studies. Learn how to use the Direct Mouse Genotyping Kit Plus in allele-screening workflows, interpret its role in the EP4 research context, and troubleshoot common PCR issues without confusing genotyping with phenotyping.

• Phenothiazines Boost Macrophage Antibacterial Defense

  2026-09-26

  Qiu and colleagues report that phenothiazines strengthen macrophage antibacterial activity alongside increased reactive oxygen species, autophagy, and lysosomal activity. Inhibitor and scavenger experiments support roles for autophagy and ROS, while a perphenazine infection model provides an initial in vivo indication of benefit; the results position host-directed therapy as a research direction, not an established treatment.

• Isochlorogenic Acid A Disrupts Multiple HBV Life-Cycle Steps

  2026-09-25

  The study finds that isochlorogenic acid A (ICAA) reduces HBV markers across several stages of the viral life cycle, alongside HO-1 upregulation and altered intracellular ROS. Its mechanistic contribution is to connect redox changes with viral particle assembly defects, while leaving open whether HO-1 catalytic activity directly causes each antiviral effect.

• Cisapride and Deep Learning in Cardiac Safety

  2026-09-25

  Cisapride (R 51619) offers a useful way to examine how serotonergic signaling and hERG channel inhibition can complicate cardiac safety readouts. This article connects its dual pharmacology to deep-learning analysis of iPSC-derived cardiomyocytes, with an emphasis on interpreting phenotypes and choosing orthogonal validation.

• Atrial Natriuretic Peptide: Practical Lab Workflows

  2026-09-24

  Turn ANP experiments into a structured workflow for vascular, renal, and metabolic assays, with practical controls for peptide handling and biological readouts. A key identity check helps distinguish the listed ANP 1-11 fragment from full-length hormone before interpreting activity.

• Go 6983: From PKC Signaling to Striatal Behavior

  2026-09-24

  Go 6983 is a pan-PKC inhibitor for probing how protein kinase C signaling may shape neuronal excitability and repetitive behavior. This article connects recent striatal research to practical assay decisions while distinguishing a mechanistic hypothesis from evidence that the compound has been tested in that model.

• MK-8745: Aurora A Inhibitor Workflows

  2026-09-23

  Use MK-8745 to connect Aurora A inhibition with mitotic arrest and apoptosis readouts, then test whether those responses depend on p53 status. A recent retinoblastoma study adds a distinct translational rationale for investigating AURKA, while not establishing MK-8745 as a validated treatment in that disease.

8136 records 1/543 page Next 12345 下5页 Last page